Use of patient preference studies in HTA decision making: a NICE perspective

16 January 2020 - Patient preference studies could provide valuable insights to a National Institute for Health and Care Excellence committee ...

Read more →

The use of risk-sharing contracts in health care: theoretical and empirical assessments

3 December 2019 - The aim of this review is to provide a summary of the literature on risk-sharing agreements, including ...

Read more →

Advancing patient engagement

2 October 2019 - It’s widely accepted that seeking patient input into their health and care improves outcomes for them and ...

Read more →

Incorporating affordability concerns within cost-effectiveness analysis for health technology assessment

27 August 2019 - New framework considers the scale, time profile, and uncertainty of budget impacts. ...

Read more →

Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art

28 July 2019 - Multi-criteria decision analysis concepts, models and tools have been used increasingly in health technology assessment, with several ...

Read more →

Stories of patient involvement impact in health technology assessments: a discussion paper

24 July 2019 - As more health technology assessment bodies seek to implement patient involvement, there is a desire to learn ...

Read more →

A non-inferiority framework for cost-effectiveness analysis

24 July 2019 - Traditional decision rules have limitations when a new technology is less effective and less costly than a ...

Read more →

NICE explores extending its use of data to inform its guidance

25 June 2019 - NICE has revised its earlier press release on the use of real world data to inform ...

Read more →

Don’t attack NICE for relying on facts instead of emotion

3 April 2019 - The National Institute for Health and Care Excellence marks its 20th anniversary this week.  ...

Read more →

Determining value in health technology assessment: stay the course or tack away?

15 February 2019 - The economic evaluation of new health technologies to assess whether the value of the expected health benefits ...

Read more →

Patient involvement in reflective multi-criteria decision analysis to assist decision making in oncology

7 February 2019 - Patient involvement in drug evaluation decision making is increasing.  ...

Read more →

Cost-effectiveness thresholds: the past, the present and the future

23 April 2018 - Cost-effectiveness (CE) thresholds are being discussed more frequently and there have been many new developments in this ...

Read more →

The use of MCDA in HTA: great potential, but more effort needed

18 April 2018 - The potential for multi-criteria decision analysis (MCDA) to support health technology assessment (HTA) has been much discussed, ...

Read more →

Decision components of NICE's technology appraisals assessment framework

10 April 2018 - The UK's NICE is an established health technology assessment agency. de Folter et al. present a ...

Read more →

Using real world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies

21 March 2018 - This study examines whether real world data is incorporated in health technology assessment (HTA) of melanoma drugs ...

Read more →